“A leading figure in patent litigation relating to generic drugs. He enjoys a broad client base in the pharmaceutical industry given his considerable experience.”
Chambers 2024
Training
Master in Industrial and Intellectual Property from Alicante University (Magister Lvcentinvs).
Graduate in Law from Barcelona University.
Professional Experience
Javier joined GRAU & ANGULO in 2003 and was a partner from 2005 to 2024 and has been Of Counsel since 2025.
Co-heading the firm’s team for advice and litigation on pharmaceutical patents for twenty years, Javier has formed an excellent portfolio of clients, and he has acted in the most significant pharmaceutical patent cases in Spain, including litigation regarding blockbuster drugs such as Cipralex® (escitalopram), Viagra® (sildenafil), Exelon® (rivastigmine), Valcyte® (valganciclovir), Lyrica® (pregabalin), Yasminelle® (drospirenone), Seroquel® (quetiapine), Bonviva® (ibandronate), Tracleer® (bosentan), Exforge® (valsartan/amlodipine), Cialis® (tadalafil), Faslodex® (fulvestrant), MabThera® (rituximab), Truvada® (tenofovir/emtricitabine), Inegy® (ezetimibe/simvastatin), NuvaRing® (contraceptive ring), Nexavar® (sorafenib), Gilenya® (fingolimod), Tecfidera® (dimethyl fumarate), Eliquis® (apixaban), and many more.
Areas of Practice
Patents, especially in the pharmaceutical sector.
Languages
- Spanish
- English
- Catalan
Associations
Member of the Barcelona Bar Association and AIPPI.
Acknowledgements
IAM Patent 1000 2024 – Gold Band Recommended Lawyer
Included in the 2025 edition of The Best Lawyers in Spain™ for Intellectual Property Law
Included in the 2025 edition of The Best Lawyers in Spain™ for Litigation
Recognised in Who’s Who Legal 2024, Life Sciences
